Andrew Bloecher is an experienced cancer drug researcher currently serving as a Senior Director at AstraZeneca, a position they have held since 2024. Their extensive background includes roles as a Principal Scientist, Associate Director, and Director at AstraZeneca, as well as leadership positions at Bristol Myers Squibb and other organizations. Andrew earned a Ph.D. in Biochemistry and Molecular Biology from Louisiana State University Medical Center and has conducted significant research, including a Damon Runyon Fellowship at the Fred Hutchinson Cancer Research Center.
This person is not in the org chart
This person is not in any teams
This person is not in any offices